Maynard Nexsen Shareholder elected to MUSC Board of Visitors
April 2, 2025
Maynard Nexsen, a full-service law firm with 31 locations across the United States, announced that Bo Russell, Shareholder, was elected to serve on the Board of Visitors for the Medical University of South Carolina (MUSC).
The Board of Visitors is vital in advancing the mission of MUSC, the most comprehensive academic health services system in the state, while also strengthening relationships of MUSC within the communities it serves. Members are nominated by the University’s trustees and serve as ambassadors in their respective regions.
Bo is an attorney in Maynard Nexsen’s Greenville office, where he supports clients throughout all stages of their business life cycle, including formation, debt and equity financing, organic and acquisitive growth, and, in many cases, a successful exit from the market.
MUSC’s purpose is to preserve and optimize human life in South Carolina and beyond. The University provides an interprofessional environment for learning and discovery through the education of health care professionals and biomedical scientists, research in the health sciences and provision of comprehensive health care.
About Maynard Nexsen
Maynard Nexsen is a full-service law firm of nearly 600 attorneys in 31 locations from coast to coast across the United States. Maynard Nexsen was formed in 2023 when two successful, client-centered firms combined to create a powerful national team. Maynard Nexsen’s list of clients spans a wide range of industry sectors and includes both public and private companies.
About the Medical University of South Carolina (MUSC)
Founded in 1824 in Charleston, MUSC is the state’s only comprehensive academic health system, with a unique mission to preserve and optimize human life in South Carolina through education, research and patient care. Each year, MUSC educates over 3,100 students in six colleges and trains more than 950 residents and fellows across its health system. MUSC leads the state in federal and National Institutes of Health and research funding.
